Elaitra Company
Elaitra’s breast cancer platform includes a Generative LLM for voice-based patient engagement, and a unique AI reading tool that helps doctors read 3D X-Rays. Operating in USA & UK. FDA 510(k) and UK regulator approved.
Technology:
AI-based Diagnostics and Imaging
Industry:
Clinical AI
Founded Date:
2018-01-01 00:00:00
Headquarters:
San Francisco,California,United States,North America
Funding Status:
private